Brief: Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement With Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.
30/11/2022 13:38
Nov 30 (Reuters) - Novo Integrated Sciences Inc
NVOS.O :
* NOVO INTEGRATED SCIENCES’ SUBSIDIARY, CLINICAL CONSULTANTS
INTERNATIONAL, SIGNS CONSULTING AGREEMENT WITH PHARMACEUTICAL
RESEARCH & DEVELOPMENT COMPANY, SARFEZ PHARMACEUTICALS, INC.
Source text for Eikon: ID:nBw10Lq0a
Further company coverage: NVOS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Novo Integrated Sciences
See all newsBrief: Novo Integrated Sciences Says On Nov 4, Got Letter From Nasdaq Indicating Co's Common Stock Will Be Delisted From Nasdaq
Brief: Novo Integrated Sciences Gets Commencement Of Disbursement Notice For SBLC Leasing And Monetizing Program
Brief: Novo Integrated Sciences Inc Files For Offering Of 3.5 Million Shares Of Common Stock By Selling Securityholder - SEC Filing
Brief: Novo Integrated Sciences Receives Confirmation Of Issuance Of SBLC By HSBC
U.S. STOCKS ON THE MOVE-Nordstrom, Foot Locker, VF Corp